170 related articles for article (PubMed ID: 18608095)
1. Clinical phenotypes and natural progression for motor neuron disease: analysis from an Australian database.
Talman P; Forbes A; Mathers S
Amyotroph Lateral Scler; 2009 Apr; 10(2):79-84. PubMed ID: 18608095
[TBL] [Abstract][Full Text] [Related]
2. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
[TBL] [Abstract][Full Text] [Related]
3. [Survival in amyotrophic lateral sclerosis].
Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
[TBL] [Abstract][Full Text] [Related]
4. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
[TBL] [Abstract][Full Text] [Related]
5. Natural history of young-adult amyotrophic lateral sclerosis.
Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P
Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
[TBL] [Abstract][Full Text] [Related]
7. The natural history of primary lateral sclerosis.
Gordon PH; Cheng B; Katz IB; Pinto M; Hays AP; Mitsumoto H; Rowland LP
Neurology; 2006 Mar; 66(5):647-53. PubMed ID: 16534101
[TBL] [Abstract][Full Text] [Related]
8. [A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS].
Kimura F; Fujimura C; Ishida S; Hosokawa T; Sato T; Nakajima H; Furutama D; Sugino M
Rinsho Shinkeigaku; 2007 Apr; 47(4):140-6. PubMed ID: 17511283
[TBL] [Abstract][Full Text] [Related]
9. [Phenotypes in ALS--clinical features and pathology].
Sasaki S
Brain Nerve; 2007 Oct; 59(10):1013-21. PubMed ID: 17969341
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with survival in the National Registry of Veterans with ALS.
Pastula DM; Coffman CJ; Allen KD; Oddone EZ; Kasarskis EJ; Lindquist JH; Morgenlander JC; Norman BB; Rozear MP; Sams LA; Sabet A; Bedlack RS
Amyotroph Lateral Scler; 2009; 10(5-6):332-8. PubMed ID: 19922120
[TBL] [Abstract][Full Text] [Related]
11. Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS.
Sabatelli M; Zollino M; Luigetti M; Grande AD; Lattante S; Marangi G; Monaco ML; Madia F; Meleo E; Bisogni G; Conte A
Amyotroph Lateral Scler; 2011 Jul; 12(4):278-82. PubMed ID: 21702734
[TBL] [Abstract][Full Text] [Related]
12. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis.
Liu XX; Zhang J; Zheng JY; Zhang S; Xu YS; Kang DX; Fan DS
Muscle Nerve; 2009 Mar; 39(3):304-9. PubMed ID: 19208412
[TBL] [Abstract][Full Text] [Related]
13. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
[TBL] [Abstract][Full Text] [Related]
14. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
15. The natural history of ALS is changing: improved survival.
Qureshi M; Schoenfeld DA; Paliwal Y; Shui A; Cudkowicz ME
Amyotroph Lateral Scler; 2009; 10(5-6):324-31. PubMed ID: 19922119
[TBL] [Abstract][Full Text] [Related]
16. The value of database controls in pilot or futility studies in ALS.
Czaplinski A; Haverkamp LJ; Yen AA; Simpson EP; Lai EC; Appel SH
Neurology; 2006 Nov; 67(10):1827-32. PubMed ID: 17130417
[TBL] [Abstract][Full Text] [Related]
17. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
Pinto S; Pinto A; De Carvalho M
Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
[TBL] [Abstract][Full Text] [Related]
18. Isolated bulbar phenotype of amyotrophic lateral sclerosis.
Burrell JR; Vucic S; Kiernan MC
Amyotroph Lateral Scler; 2011 Jul; 12(4):283-9. PubMed ID: 21702735
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.
De Groot IJ; Post MW; van Heuveln T; Van den Berg LH; Lindeman E
Amyotroph Lateral Scler; 2007 Dec; 8(6):356-61. PubMed ID: 18033593
[TBL] [Abstract][Full Text] [Related]
20. ALSFRS and appel ALS scores: discordance with disease progression.
Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
